FDA Inspection 1005796 - GlaxoWellcome Production - March 03, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns GlaxoWellcome Production, with an inspection on March 3, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: GlaxoWellcome Production
Inspection Date: March 3, 2017
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · b673f0a0-aaff-450b-b76a-74f9a1411f35

Violation Codes1

21 CFR 314.81(b)(1)(ii)

Full citation text and observation details available on the Dashboard.